Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Authors
Keywords
-
Journal
mBio
Volume 12, Issue 2, Pages -
Publisher
American Society for Microbiology
Online
2021-04-19
DOI
10.1128/mbio.00765-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
- (2021) Romina Libster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
- (2021) C. Garrett Rappazzo et al. SCIENCE
- Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022
- (2021) Caroline Atyeo et al. JCI Insight
- Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
- (2021) Emma S. Winkler et al. CELL
- SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
- (2021) Hassen Kared et al. JOURNAL OF CLINICAL INVESTIGATION
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- COVID ‐19 convalescent plasma: Interim recommendations from the AABB
- (2021) Claudia S. Cohn et al. TRANSFUSION
- Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
- (2021) Savannah E. Butler et al. Frontiers in Immunology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies
- (2020) Philipp A. Ilinykh et al. Cell Host & Microbe
- Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
- (2020) Xiangyu Chen et al. Cellular & Molecular Immunology
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Deployment of convalescent plasma for the prevention and treatment of COVID-19
- (2020) Evan M. Bloch et al. JOURNAL OF CLINICAL INVESTIGATION
- The case of Complement activation in COVID-19 multiorgan impact
- (2020) Marina Noris et al. KIDNEY INTERNATIONAL
- A human neutralizing antibody targets the receptor binding site of SARS-CoV-2
- (2020) Rui Shi et al. NATURE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of SARS‐CoV ‐2 antibodies in COVID ‐19: Healing in most, harm at times
- (2020) Martyn A. French et al. RESPIROLOGY
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
- (2020) Eric Salazar et al. AMERICAN JOURNAL OF PATHOLOGY
- Earlier the better: convalescent plasma
- (2020) Aaron A. R. Tobian et al. BLOOD
- A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
- (2020) Ahmed O. Hassan et al. CELL
- Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
- (2020) Caroline Atyeo et al. IMMUNITY
- A perspective on potential antibody-dependent enhancement of SARS-CoV-2
- (2020) Ann M. Arvin et al. NATURE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Broad neutralization of SARS-related viruses by human monoclonal antibodies
- (2020) Anna Z. Wec et al. SCIENCE
- Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
- (2020) Huibin Lv et al. Cell Reports
- Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS
- (2020) Walter Fierz et al. Frontiers in Immunology
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
- (2020) Sabra L. Klein et al. JOURNAL OF CLINICAL INVESTIGATION
- SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
- (2020) Sarah E Benner et al. JOURNAL OF INFECTIOUS DISEASES
- Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
- (2020) Sean T. H. Liu et al. NATURE MEDICINE
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
- (2020) Ellen Shrock et al. SCIENCE
- Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
- (2020) M. Alejandra Tortorici et al. SCIENCE
- Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
- (2020) Eric Salazar et al. AMERICAN JOURNAL OF PATHOLOGY
- Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
- (2020) Alexandra Schäfer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
- (2020) Jéromine Klingler et al. JOURNAL OF INFECTIOUS DISEASES
- Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
- (2020) Mads Delbo Larsen et al. SCIENCE
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma
- (2020) Tania S Bonny et al. Open Forum Infectious Diseases
- A versatile high throughput assay to characterize antibody-mediated neutrophil phagocytosis
- (2019) Christina B. Karsten et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity
- (2019) James T. Earnest et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV
- (2018) Eric P. Brown et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
- (2018) Bronwyn M. Gunn et al. Cell Host & Microbe
- Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection
- (2018) Hui-Ju Han et al. Viruses-Basel
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
- (2018) Lisa E. Gralinski et al. mBio
- Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
- (2017) Eric P. Brown et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
- (2016) Carole J. Henry Dunand et al. Cell Host & Microbe
- A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
- (2015) Yan Li et al. CELL RESEARCH
- Highly parallel characterization of IgG Fc binding interactions
- (2014) Austin W Boesch et al. mAbs
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
- (2014) Christopher M. Coleman et al. VACCINE
- Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
- (2014) Fumihiko Yasui et al. VIROLOGY
- Determining the Phagocytic Activity of Clinical Antibody Samples
- (2011) Elizabeth G. McAndrew et al. Jove-Journal of Visualized Experiments
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
- (2010) Margaret E. Ackerman et al. JOURNAL OF IMMUNOLOGICAL METHODS
- An immunosuppressed Syrian golden hamster model for SARS-CoV infection
- (2008) Scott R. Schaecher et al. VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started